Hyperfractionated external beam radiation therapy in the treatment of murine transgenic retinoblastoma

Archives of Ophthalmology

Volumn 120, Issue 3, 2002, Pages 353-359

  Hayden, Brandy C ^a   Murray, Timothy G ^a,b   Cicciarelli, Nicole ^a   Scott, Ingrid U ^a   Alexandridou, Anastassia ^a   Hernandez, Eleut ^a   Wu, Xiaodong ^b   Markoe, Arnold M ^a,b   Feuer, William ^a   Fulton, Lilia ^c   O'Brien, Joan M ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS LARGE T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEAM THERAPY; CANCER CONTROL; CONTROLLED STUDY; DOSE RESPONSE; FRACTIONATION; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RETINOBLASTOMA; SIMIAN VIRUS 40; TRANSGENE;

EID: 0036129197     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.120.3.353     Document Type: Article

References (58)

1. Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene
2. Second nonocular tumors in survivors of heritable retinoblastoma
3. Incidence of second neoplasms in patients with bilateral retinoblastoma
4. The incidence of retinoblastoma in the United States: 1974 through 1985
5. Recent developments in the management of retinoblastoma
6. Retinoblastoma: A review emphasizing genetics and management strategies
7. Current management of retinoblastoma
8. The practical management of retinoblastoma
9. Radiotherapy of retinoblastoma: A review of 63 children treated with different irradiation techniques
10. Chemotherapy in the treatment of retinoblastoma
11. External beam radiation for retinoblastoma: Results, patterns of failure, and a proposal for treatment guidelines
12. External beam radiotherapy for retinoblastoma, I: Whole eye technique
13. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma
14. Incidence of second primary tumours among childhood cancer survivors
15. Whole-eye versus lens-sparing megavoltage therapy for retinoblastoma
16. Patterns of multiple primary tumours in patients treated for cancer during childhood
17. Mortality from second tumors among long-term survivors of retinoblastoma
18. Second non-ocular tumors in retinoblastoma survivors: Are they radiation induced?
19. Second nonocular tumors in survivors of bilateral retinoblastoma: A possible age effect on radiation-related risk
20. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck
21. Fractionated external beam radiation therapy for meningiomas of the cavernous sinus
22. Treatment of retinoblastoma vitreous base seeding
23. Pediatric radiotherapy
24. Hyperfractionated radiotherapy: Tops or flops?
25. Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy
26. Hyperfractionated radiotherapy in head and neck cancer: A second look at the clinical data
27. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors
28. Hyperfractionated radiotherapy in brain stem tumors: Results of a Pediatric Oncology Group Study
29. Final results of a study of escalating dose of hyperfractionated radiotherapy in brain stem tumors in children: A Pediatric Oncology Group Study
30. Hyperfractionated radiation in children with rhabdomyosarcoma: Results of an Intergroup Rhabdomyosarcoma Pilot Study
31. Local control and function after twice-a-day radiotherapy for Ewing's sarcoma of bone
32. External beam radiotherapy in retinoblastoma: A comparison of 2 techniques
33. Retinoblastoma: A study of 139 cases
34. External beam irradiation for retinoblastoma: Patterns of failure and dose-response analysis
35. Effects of ionizing radiation on retinoblastoma and on the normal ocular fundus in infants: A photographic and fluorescein angiographic study
36. Trilateral retinoblastoma in transgenic mice
37. Retinoblastoma in transgenic mice
38. A transgenic mouse model for trilateral retinoblastoma
39. Retinoblastoma in transgenic mice: Models of hereditary retinoblastoma
40. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma
41. Radiation therapy and ferromagnetic hyperthermia in the treatment of murine transgenic retinoblastoma
42. Retinoblastoma after chemoreduction and irradiation: Preliminary results
43. Clinicopathologic features of retinoblastoma after primary chemoreduction
44. Chemoreduction in the initial management of intraocular retinoblastoma
45. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma
46. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma
47. Chemotherapy for retinoblastoma: A current topic
48. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy
49. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma
50. Chemotherapy plus local treatment in the management of intraocular retinoblastoma
51. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma
52. Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy
53. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma
54. Local carboplatin therapy in transgenic murine retinoblastoma
55. Intraocular concentrations of chemotherapeutic agents after systemic or local administration
56. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma